Women with increased breast density are targeted significantly more for supplemental imaging than those without dense tissue, but there are other factors that increase the risk of mammography screening failure that should also be considered, according to new data.

The findings support adopting F-18 DCFPyL PET/CT as the standard of care for prostate cancer staging, authors of a new Scientific Reports paper concluded.

The USPSTF’s update suggests that women should screen every other year, but the group's own modeling studies have cited the benefits of annual screening.

The task force cited insufficient evidence as the driver behind the decision to forego recommending supplemental screening. 

These findings highlight a need for more stringent and standardized reporting guidelines relative to incidental findings, authors of the new study suggested.

Radiologists interpreting screening mammograms may be especially susceptible to falling victim to automation bias, as these exams are repetitive in nature.

Breast density is known to drop over time, but the rate at which density decreases merits special attention, as it could be associated with a woman’s chance of developing cancer.

That’s according to an award-winning scientific online poster presented this week during the American Roentgen Ray Society’s annual meeting being held in Honolulu, Hawaii.